Zobrazeno 1 - 3
of 3
pro vyhledávání: '"O. M. Strizhakova"'
Autor:
Yu. A. Nikonova, S. G. Abbasova, P. E. Kargopolova, O. M. Strizhakova, I. V. Lyagoskin, A. P. Vasilev, A. S. Pershin
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 14, Iss 3, Pp 317-329 (2024)
INTRODUCTION. Bioanalytical techniques are characterised by greater variability and lower stability than physicochemical methods because live test systems are inherently labile. Since regulatory standards do not establish a unified approach, the sele
Externí odkaz:
https://doaj.org/article/ee387463937542498c2e3d73d9b3ce55
Autor:
D. A. Poteryaev, S. G. Abbasova, P. E. Ignatyeva, O. M. Strizhakova, S. V. Kolesnik, R. A. Khamitov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 21, Iss 3, Pp 178-192 (2021)
With the onset of the COVID-19 pandemic, a number of molecular-based tests have been developed to diagnose SARS-CoV-2 infection. However, numerous available serological tests lack sufficient sensitivity or specificity. They do not detect specific ant
Externí odkaz:
https://doaj.org/article/4cb802dafa41407c80ad4f74e8dacd73
Autor:
I. V. Lyagoskin, M. S. Pantyushenko, O. M. Strizhakova, N. K. Kudina, E. Yu. Prudnikova, P. V. Chichkanova, S. G. Abbasova
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 20, Iss 1, Pp 42-49 (2020)
Enzyme replacement therapy (ERT) is one of the most efficient treatments for lysosomal storage diseases. Type 1 Gaucher disease is caused by β-glucocerebrosidase enzyme deficiency, which may be compensated for by intravenous infusions of imigluceras
Externí odkaz:
https://doaj.org/article/a507e5c6a71d4d2386c1c73253d6fa87